An Impact Player Joins the Probiotech Team.

SAINT-HYACINTHE, Quebec--(BUSINESS WIRE)--

Probiotech International Inc. is moving forward. We are very excited to announce the arrival of Mr. Yves Bellemare to the Probiotech team as Vice President and Chief Sales Officer. In his role, Yves will have direct responsibility for the Company's entire salesforce. He will oversee the sales and development team and will simultaneously coordinate the implementation of the sales strategy and process.

With nearly 35 years of experience in strategy, sales, and business development, Yves will bring significant expertise in growth management in Canada and internationally to the team. His knowledge of markets and business processes will enable Probiotech to strengthen its customer service and respond even more effectively to market trends. Yves' arrival at the Probiotech team confirms the Company's vision and determination to accelerate its growth across North America, but above all to consolidate its commitment to innovation, quality, and service for the benefit of its clients.

The whole team joins me in thanking Yves for his commitment to our joint project. We welcome him to our family and wish him the very best of success. Welcome, Yves!

Frederick Perrault, CA, CPA, MSc.
Executive Chairman of the Board

Ivan Girard, Ph.D., PAS
President and Chief Innovation Officer

Source: Probiotech International Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260218356093/en/

Information: [email protected] | 450-771-7252

Source: Probiotech International Inc.

You May Also Be Interested In

• Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
• Monster Energy and Call of Duty® Take Over Cosm Los Angeles for Immersive Modern Warfare® 4 Launch Celebration
• Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Pati